BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9569729)

  • 1. [Cytokines in rheumatoid arthritis: new therapeutic possibilities].
    Szekanecz Z; Szegedi G
    Orv Hetil; 1998 Apr; 139(14):819-23. PubMed ID: 9569729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytokines and their antagonists in the treatment of rheumatoid arthritis].
    Klimiuk PA; Sierakowski S
    Przegl Lek; 2002; 59(2):108-12. PubMed ID: 12152246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
    Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
    J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
    Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
    Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
    Bondeson J; Maini RN
    Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.
    Szekanecz Z; Koch AE; Kunkel SL; Strieter RM
    Drugs Aging; 1998 May; 12(5):377-90. PubMed ID: 9606615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine network and its manipulation in rheumatoid arthritis.
    Malaviya AM
    J Assoc Physicians India; 2006 Jun; 54 Suppl():15-8. PubMed ID: 16909710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
    Sugiyama E
    Clin Calcium; 2007 Apr; 17(4):528-34. PubMed ID: 17404481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
    Montecucco F; Mach F
    Rheumatology (Oxford); 2009 Jan; 48(1):11-22. PubMed ID: 18927189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis.
    Abramson SB; Yazici Y
    Adv Drug Deliv Rev; 2006 May; 58(2):212-25. PubMed ID: 16567019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cartilage destruction and novel nonsurgical therapeutic strategies to retard cartilage injury in rheumatoid arthritis.
    Häuselmann HJ
    Curr Opin Rheumatol; 1997 May; 9(3):241-50. PubMed ID: 9204260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokines in the pathogenesis of rheumatoid arthritis.
    Feldmann M; Maini RN
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokines in rheumatoid arthritis. I. Proinflammatory cytokines].
    Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2001 Dec; 11(66):510-3. PubMed ID: 11899850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update in rheumatoid arthritis therapy.
    Kim-Howard XR; Staudt L; James JA
    J Okla State Med Assoc; 2005 Feb; 98(2):53-62. PubMed ID: 15789642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokines in rheumatoid arthritis. II. Anti-inflammatory cytokines].
    Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2001 Dec; 11(66):514-6. PubMed ID: 11899851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early rheumatoid arthritis.
    Machold KP; Nell V; Stamm T; Aletaha D; Smolen JS
    Curr Opin Rheumatol; 2006 May; 18(3):282-8. PubMed ID: 16582693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
    Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
    Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines in the pathogenesis of rheumatoid arthritis.
    McInnes IB; Schett G
    Nat Rev Immunol; 2007 Jun; 7(6):429-42. PubMed ID: 17525752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.